investments Indraprastha Medical Corp’s re-rating hinges on Delhi govt. stake sale; maintaining it as top pick for target price of ₹590 (44% upside): Anand Rathi Arjun June 26, 2025 We recently hosted in Mumbai the Indraprastha Medical management for an NDR. Key takeaways:...Read More
